BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25362804)

  • 1. Synthesis and anti-mycobacterial activity of new 4-thiazolidinone and 1,3,4-oxadiazole derivatives of isoniazid.
    Bhat MA
    Acta Pol Pharm; 2014; 71(5):763-70. PubMed ID: 25362804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antimicrobial evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid.
    Gilani SJ; Khan SA; Alam O; Siddiqui N
    Acta Pol Pharm; 2011; 68(2):205-11. PubMed ID: 21485293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
    Ahsan MJ; Samy JG; Khalilullah H; Nomani MS; Saraswat P; Gaur R; Singh A
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7246-50. PubMed ID: 22071303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines.
    Navarrete-Vázquez G; Molina-Salinas GM; Duarte-Fajardo ZV; Vargas-Villarreal J; Estrada-Soto S; González-Salazar F; Hernández-Núñez E; Said-Fernández S
    Bioorg Med Chem; 2007 Aug; 15(16):5502-8. PubMed ID: 17562368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
    Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
    Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
    Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
    Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
    Ambhore AN; Kamble SS; Kadam SN; Kamble RD; Hebade MJ; Hese SV; Gaikwad MV; Meshram RJ; Gacche RN; Dawane BS
    Comput Biol Chem; 2019 Jun; 80():54-65. PubMed ID: 30901601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation.
    Ramani AV; Monika A; Indira VL; Karyavardhi G; Venkatesh J; Jeankumar VU; Manjashetty TH; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2764-7. PubMed ID: 22440626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.
    Kumar A; Patel G; Menon SK
    Chem Biol Drug Des; 2009 May; 73(5):553-7. PubMed ID: 19366360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
    Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.
    Swamy BN; Suma TK; Rao GV; Reddy GC
    Eur J Med Chem; 2007 Mar; 42(3):420-4. PubMed ID: 17112641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
    Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
    Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
    Aboul-Fadl T; Bin-Jubair FA; Aboul-Wafa O
    Eur J Med Chem; 2010 Oct; 45(10):4578-86. PubMed ID: 20696500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of various substituted oxadiazole derivatives.
    Kaur H; Kumar S; Verma RS; Garg A; Saxena KK; Lata S; Kumar A
    Arch Pharm (Weinheim); 2011 Jul; 344(7):466-73. PubMed ID: 21500249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antimicrobial activity of some novel oxadiazole derivatives.
    Islam M; Siddiqui AA; Rajesh R; Bakht A; Goyal S
    Acta Pol Pharm; 2008; 65(4):441-7. PubMed ID: 19051585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
    Macaev F; Rusu G; Pogrebnoi S; Gudima A; Stingaci E; Vlad L; Shvets N; Kandemirli F; Dimoglo A; Reynolds R
    Bioorg Med Chem; 2005 Aug; 13(16):4842-50. PubMed ID: 15993090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.